Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Stroke × Neuropsychological Tests × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 12 Cognitive Dysfunction 4 Radiation Injuries 3 Neoplasms 3 Glioma 3 Breast Neoplasms 3 Multiple Myeloma 2 Glioblastoma 2 Fatigue 2 Colorectal Neoplasms 2 Astrocytoma 2 Triple Negative Breast Neoplasms 1 Stroke 1 Sarcoma 1 Prostatic Neoplasms 1 Pituitary Neoplasms 1 Parkinson Disease 1 Osteosarcoma 1 Oligodendroglioma 1 Neurofibromatosis 1 1 Neuroendocrine Tumors 1 Neoplasm Metastasis 1 Meningioma 1 Medulloblastoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell 1 Lymphoma 1 Lung Neoplasms 1 Localized, Operable Non-small Cell Lung Cancer 1

Interventions

Transcranial Direct Current Stimulation 2 Nutrition Assessment 2 tocilizumab 1 rimabotulinumtoxinB 1 X-Rays 1 Vitamin B 6 1 Vitamin B 12 1 Thrombectomy 1 Standard of Care 1 Rosuvastatin Calcium 1 Practice Guidelines as Topic 1 Phenylephrine 1 Norepinephrine 1 Neuropsychological Tests 1 Music Therapy 1 Massage 1 Lysine Acetyltransferase 5 1 Infliximab 1 Immunoglobulin G 1 Folic Acid 1 Exergaming 1 Enoxaparin 1 Disulfides 1 Dialectical Behavior Therapy 1 Cholecalciferol 1 Cerebral Angiography 1 Botulinum Toxins, Type A 1 Aspirin 1 Animal Assisted Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05791006 2023-03-30

NEUROFIN

Istituto Auxologico Italiano

Brain Neoplasms, Parkinson Disease, Stroke

Data powered by HemOnc (CC BY 4.0) Colophon ⚡